The main GLP-1 agonist names in India include semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro), liraglutide (Victoza, Saxenda, Lirafit), dulaglutide (Trulicity), and exenatide (Byetta)
doi: 10.1038/s41467-022-28683-0 127 KnerrPJMowerySADourosJDPremdjeeBHjllundKRHeYet al
These pathways may also prevent pathological fibrosis by blocking TGF-/Smad signaling and downregulating ANP/BNP expression
27 Higher doses of tirzepatide were noted to significantly ameliorate biomarkers related to fatty liver while increasing adiponectin levels in T2DM
By month 3, most users describe eating as purely functional
Nausea is a common side effect of GLP-1 medications, which are often prescribed for weight management or diabetes